Haemonetics
HAE
HAE
292 hedge funds and large institutions have $5.92B invested in Haemonetics in 2018 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 71 increasing their positions, 146 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $3.42M | Put options by funds: $4.35M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
51% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 146
Holders
292
Holding in Top 10
2
Calls
$3.42M
Puts
$4.35M
Top Buyers
| 1 | +$296M | |
| 2 | +$80.4M | |
| 3 | +$52.9M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$52.7M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$48.6M |
Top Sellers
| 1 | -$45.6M | |
| 2 | -$41.7M | |
| 3 | -$31.1M | |
| 4 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
-$29.1M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$28.9M |